References
- Angelkort B., Kiesewetter H. Influence of risk factors and coagulation phenomena on the fluidity of blood in chronic arterial occlusive disease. Scand. J. Clin. Lab. Invest. 1984; 41: 185–1881. Angelkort B., Kiesewetter H. Influence of risk factors and coagulation phenomena on the fluidity of blood in chronic arterial occlusive disease. Scand. J. Clin. Lab. Invest. 1984; 41: 185–188
- Barbarino C., Schiavon S., Paterna S., Rizzo M., Serena A., Pezzangora V. Sull'attivitá terapeutica della pentossifillina nell'insufficienza venosa cronica degli arti inferiori complicata da ulcera trofica. Risultati preliminari. Minerva Angiol. 1991; 16: 267–2692. Barbarino C., Schiavon S., Paterna S., Rizzo M., Serena A., Pezzangora V. Sull'attivitá terapeutica della pentossifillina nell'insufficienza venosa cronica degli arti inferiori complicata da ulcera trofica. Risultati preliminari. Minerva Angiol. 1991; 16: 267–269
- Bertocchi R, Proserpio P., Lampugnani M. G., Dejana E. The effects of pentoxifylline on polymorphonuclear cell adhesion to cultured endothelial cells. A preliminary report. “Pentoxifylline and Leukocyte Function”, G. L. Mandell, W. J. Novick. Hoechst-Roussel Pharmaceuticals, Somerville, N.J. 1988; 96–1043. Bertocchi R, Proserpio P., Lampugnani M. G., Dejana E. The effects of pentoxifylline on polymorphonuclear cell adhesion to cultured endothelial cells. A preliminary report. “Pentoxifylline and Leukocyte Function”, G. L. Mandell, W. J. Novick. Hoechst-Roussel Pharmaceuticals, SomervilleN.J. 1988; 96–104
- Browse N. L., Burnand K. G. The cause of venous ulceration. Lancet 1982; 2: 243–2454. Browse N. L., Burnand K. G. The cause of venous ulceration. Lancet 1982; 2: 243–245
- Coleridge Smith P. D., Thomas P., Scurr J. H., Dormandy J. A. Causes of venous ulceration: a new hypothesis. Br. Med. J. 1988; 296: 1726–17275. Coleridge Smith P. D., Thomas P., Scurr J. H., Dormandy J. A. Causes of venous ulceration: a new hypothesis. Br. Med. J. 1988; 296: 1726–1727
- James D. R., Holland B. M., Hughes M. R., Jones J. G., Wardrop C. A. J. Oxpentifylline: effects on red cell deformability and oxygen availability from the blood in intermittent claudication. Clin. Hemorheol. 1984; 4: 525–5316. James D. R., Holland B. M., Hughes M. R., Jones J. G., Wardrop C. A. J. Oxpentifylline: effects on red cell deformability and oxygen availability from the blood in intermittent claudication. Clin. Hemorheol. 1984; 4: 525–531
- Knox P. Leukocyte-mediated activation of the fibrinolytic pathway and effects of pentoxifylline. “Pentoxifylline and Leukocyte Function”, G. L. Mandell, W. J. Novick. Hoechst-Roussel Pharmaceuticals, Somerville, N.J. 1988; 68–747. Knox P. Leukocyte-mediated activation of the fibrinolytic pathway and effects of pentoxifylline. “Pentoxifylline and Leukocyte Function”, G. L. Mandell, W. J. Novick. Hoechst-Roussel Pharmaceuticals, SomervilleN.J. 1988; 68–74